Skip to main content
Premium Trial:

Request an Annual Quote

Illumina, Caliper Strike Co-Marketing Pact

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Caliper Life Sciences and Illumina will co-market Caliper's library sample preparation and analysis and quality control tools with Illumina's genome sequencing platforms, Caliper said today.

Caliper said the firms have signed an agreement covering marketing for its LabChip XT library preparation tool and its LabChip GX quality control platform for use with Illumina's Genome Analyzer and HiSeq2000 systems.

The LabChip XT is used to replace gel isolation steps in the sequencing library prep process, and the GX uses microfluidics technology to perform electrophoretic separations for analyzing DNA or RNA size, concentration, or integrity.

"The LabChip XT in particular was developed with direct input from Illumina and we are excited to enter into this co-marketing agreement to promote both LabChip products to address critical bottlenecks in sample preparation of next-generation sequencing libraries," Caliper CEO and President Kevin Hrusovsky said in a statement.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.